CPG
RCEL icon

Cornerstone Planning Group’s Avita Medical RCEL Stock Holding History

Cornerstone Planning Group’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-130
Closed -$1.34K – 1475
2024
Q3 		$1.34K Buy
+130
New +$1.22K ﹤0.01% 868

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cornerstone Planning Group's RCEL Position: Q4 2024 in Review

Cornerstone Planning Group sold out of Avita Medical (RCEL) in Q4 2024, closing a stake of 130 shares — an estimated $1.34K sold.

Cornerstone Planning Group first reported a position in RCEL in Q3 2024 and held it in 1 quarter. The position peaked at $1.34K in Q3 2024. 73 funds tracked by Wall St. Rank hold RCEL as of Q4 2024.

  • Cornerstone Planning Group reported no remaining Avita Medical position as of Q4 2024 after selling out during the quarter.
  • Cornerstone Planning Group sold 130 Avita Medical shares in Q4 2024, an estimated $1.34K.
  • Cornerstone Planning Group first reported a position in Avita Medical in Q3 2024 and held it in 1 quarter.
  • Cornerstone Planning Group's Avita Medical position peaked at $1.34K in Q3 2024.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q4 2024.

Based on Cornerstone Planning Group's 13F filing for Q4 2024, filed 29 Jan 2025.